Abstracts tagged "Validity and ankylosing spondylitis (AS)"

Abstract Number: 1635 • 2018 ACR/ARHP Annual Meeting
Validity of Patient-Reported Outcomes Measurement Information System Measures in Ankylosing Spondylitis Patients
Mark Hwang¹, Alexis Ogdie² and John D. Reveille³, ¹Internal Medicine-Rheumatology, University of Texas-McGovern Medical School, Houston, TX, ²Medicine/Rheumatology and Epidemiology, University of Pennsylvania, Philadelphia, PA, ³Rheumatology, McGovern Medical School at the University of Texas Health Science Center at Houston, USA, Houston, TX
Background/Purpose: The Patient-Reported Outcomes Measurement Information System (PROMIS) developed by the US National Institutes of Health is a patient-reported outcomes system designed to measure disease…
Abstract Number: 672 • 2015 ACR/ARHP Annual Meeting
Validity of Ankylosing Spondylitis Diagnoses in the Health Improvement Network
Maureen Dubreuil^1,2, Christine Peloquin³, Yuqing Zhang⁴, Hyon Choi⁵, Robert D Inman⁶ and Tuhina Neogi⁷, ¹Rheumatology, VA Boston Healthcare System, Boston, MA, ²Rheumatology, Boston University School of Medicine, Boston, MA, ³Clinical Epidemiology Unit, Boston University School of Medicine, Boston, MA, ⁴BUSM, Boston, MA, ⁵Division of Rheumatology, Allergy and Immunology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, ⁶Immunlogy and Institute of Medical Science, Toronto Western Hospital, University of Toronto, Toronto, ON, Canada, ⁷Clinical Epidemiology, BUSM, Boston, MA
Background/Purpose: Because ankylosing spondylitis (AS) is relatively uncommon, large electronic medical record (EMR) databases with longitudinal follow up offer an important opportunity for epidemiologic research…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].